Published in J Biol Chem on July 25, 1980
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med (1997) 5.10
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev (1994) 2.39
Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci U S A (1994) 2.29
Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci U S A (1983) 1.65
Thyrotropin-releasing hormone increases prolactin mRNA activity in the cytoplasm of GH-cells as measured by translation in a wheat germ cell-free system. Biochem Biophys Res Commun (1976) 1.62
Effects of thyrotropin-releasing hormone and hydrocortisone on synthesis and degradation of prolactin in a rat pituitary cell strain. J Biol Chem (1973) 1.58
Nalbuphine. Drug Alcohol Depend (1985) 1.30
Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A (1984) 1.22
Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol (1988) 1.18
(+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol (1985) 1.16
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol (2000) 1.12
Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors. J Med Chem (1986) 1.11
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors. J Med Chem (1985) 1.09
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs. J Med Chem (2000) 1.05
Thapsigargin, but not caffeine, blocks the ability of thyrotropin-releasing hormone to release Ca2+ from an intracellular store in GH4C1 pituitary cells. Biochem J (1990) 1.05
A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture. Endocrinology (1976) 1.01
Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem (1980) 1.01
Peptides as receptor selectivity modulators of opiate pharmacophores. J Med Chem (1986) 1.00
Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem (1979) 0.97
17 beta-Estradiol has a biphasic effect on gh cell growth. Endocrinology (1983) 0.95
2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action. J Med Chem (1998) 0.94
Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (1997) 0.94
Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells. Mol Endocrinol (1988) 0.93
The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells. Endocrinology (1981) 0.93
The hydrolysis of phosphatidylcholine by phospholipase A2 in hamster heart. Can J Biochem Cell Biol (1984) 0.92
Anti-estrogenic compounds increase prolactin and growth hormone synthesis in clonal strains of rat pituitary cells. Endocrinology (1977) 0.91
Regulation of prolactin production and cell growth by estradiol: difference in sensitivity to estradiol occurs at level of messenger ribonucleic acid accumulation. Endocrinology (1987) 0.91
Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine. Neuropsychopharmacology (1988) 0.91
Release and synthesis of prolactin by rat pituitary cell strains are regulated independently by thyrotropin-releasing hormone. Nature (1976) 0.90
Insulin and 17 beta-estradiol increase the intracellular prolactin content of GH4C1 cells. Endocrinology (1981) 0.90
Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology (1986) 0.90
Prolactin: multiple intracellular processing routes plus several potential mechanisms for regulation. Biochem Pharmacol (1982) 0.89
TRH and BAY K 8644 synergistically stimulate prolactin release but not 45Ca2+ uptake. Am J Physiol (1988) 0.89
Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology (2000) 0.88
An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. Br J Clin Pharmacol (2005) 0.88
Hormonal control of tyrosine aminotransferase, prolactin, and growth hormone induction in somatic cell hybrids. J Steroid Biochem (1980) 0.88
Ca2+ transients induced by thyrotropin-releasing hormone rapidly lose their ability to cause release of prolactin. Mol Endocrinol (1989) 0.87
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. Bull Exp Biol Med (2001) 0.87
Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. J Pharmacol Exp Ther (1986) 0.87
The purification and characterization of a phospholipase A in hamster heart cytosol for the hydrolysis of phosphatidylcholine. J Biol Chem (1987) 0.86
Synergistic stimulation of prolactin release by phorbol ester, A23187 and forskolin. Biochem Biophys Res Commun (1984) 0.86
Light sensitive zinc content of protein fractions from bovine rod outer segments. Biochem Biophys Res Commun (1976) 0.85
2-Bromo-alpha-ergocryptine causes degradation of prolactin in primary cultures of rat pituitary cells after chronic treatment. J Biol Chem (1980) 0.85
Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic. J Cell Sci (2001) 0.85
A multifunctional cyclic nucleotide- and Ca2+-independent protein kinase from rabbit skeletal muscle. Biochem Biophys Res Commun (1982) 0.84
Bombesin stimulates inositol polyphosphate production in GH4C1 pituitary tumor cells: comparison with TRH. Biochem Biophys Res Commun (1988) 0.84
Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology (1989) 0.83
Rat growth hormone gene expression is correlated with an unmethylated CGCG sequence near the transcription initiation site. Biochemistry (1986) 0.83
Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices. J Pharmacol Exp Ther (1994) 0.82
Structural properties of bovine brain S-100 protein. J Biol Chem (1971) 0.82
Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells. Mol Pharmacol (1993) 0.82
Ability of repetitive Ca2+ spikes to stimulate prolactin release is frequency dependent. Biochem Biophys Res Commun (1989) 0.82
Demonstration of subunits in beef brain acidic protein (S-100). Biochem Biophys Res Commun (1969) 0.82
Selective reversible and irreversible ligands for the kappa opioid receptor. J Med Chem (1992) 0.82
Thyrotropin-releasing hormone-mediated Mn2+ entry in perifused rat anterior pituitary cells. Biochem J (1992) 0.82
High-throughput genomic and proteomic analysis using microarray technology. Clin Chem (2001) 0.82
Regulation of parathyroid hormone-related peptide gene expression by estrogen in GH4C1 rat pituitary cells has the pattern of a primary response gene. J Neurochem (1994) 0.81
Prolactin storage in a clonal strain of rat pituitary tumor cells is cell-cycle dependent. J Cell Biol (1982) 0.81
Synthesis and opioid activity of 7-oxygenated 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolin-9-ols. J Med Chem (1994) 0.81
Is a sorting signal necessary to package proteins into secretory granules? Mol Cell Endocrinol (1991) 0.81
Dopamine has no effect on thyrotropin-releasing hormone mobilization of calcium from intracellular stores in rat anterior pituitary cells. Mol Endocrinol (1988) 0.80
Differential interaction of rabbit skeletal muscle phosphorylase kinase isozymes with calmodulin. J Biol Chem (1980) 0.80
Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine. Endocrinology (1994) 0.80
KN-62, a calcium/calmodulin-dependent protein kinase II inhibitor, inhibits high potassium-stimulated prolactin secretion and intracellular calcium increases in anterior pituitary cells. Biochim Biophys Acta (1996) 0.80
Difference in calcium requirements for forskolin-induced release of prolactin from normal pituitary cells and GH4C1 cells in culture. Endocrinology (1984) 0.79
Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent. Mol Cell Biol Res Commun (2000) 0.79
Somatic cell hybridization of growth hormone-producing rat pituitary cells and mouse fibroblasts results in extinction of growth hormone expression via a defect in growth hormone RNA production. J Biol Chem (1982) 0.79
Muscarinic inhibition of prolactin production in cultures of rat pituitary cells. Biochem Biophys Res Commun (1981) 0.79
Stabilization of the receptor protein tyrosine phosphatase-like protein ICA512 in GH4C1 cells upon treatment with estradiol, insulin, and epidermal growth factor. Endocrinology (1998) 0.79
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci (1999) 0.79
Prolactin and insulin are targeted to the regulated pathway in GH4C1 cells, but their storage is differentially regulated. Mol Endocrinol (1990) 0.79
Selective sigma receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol (1989) 0.78
Properties of human prolactin (PRL) and H27A-PRL, a mutant that does not bind Zn++. Mol Endocrinol (1996) 0.78
Hormonal regulation of prolactin storage in a clonal strain of rat pituitary tumor cells. Yale J Biol Med (1983) 0.78
Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release. Endocrinology (1985) 0.78
Bivalent opioid peptide analogues with reduced distances between pharmacophores. Life Sci (1987) 0.78
[3H]beta-funaltrexamine binds covalently to brain opioid receptors. Eur J Pharmacol (1985) 0.78
3-Substituted, 3-(4-pyridinylmethyl)-1,3-dihydro-1-phenyl-2H-indol-2-ones as acetylcholine release enhancers: synthesis and SAR. J Med Chem (1993) 0.78
Inhibition of rat prolactin (PRL) storage by coexpression of human PRL. Mol Endocrinol (1994) 0.78
Pyroglutamyl-histidyl-prolineamide (TRH). A neurohormone which affects the release and synthesis of prolactin and thyrotropin. Isr J Med Sci (1974) 0.78
Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated. Endocrinology (1986) 0.78
Binding of thrombin to human platelet plasma membranes. Biochim Biophys Acta (1978) 0.78
Acquisition of Lubrol insolubility, a common step for growth hormone and prolactin in the secretory pathway of neuroendocrine cells. J Biol Chem (2001) 0.77
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels. Life Sci (2003) 0.77
[3H]linopirdine (DuP 996) labels a novel binding site in rat brain involved in the enhancement of stimulus-induced neurotransmitter release: autoradiographic localization studies. Brain Res (1992) 0.77
Synthesis and biological activity of 5-fluoroimidazole-TRH. Biochem Biophys Res Commun (1983) 0.77
Action of cholera toxin on hormone synthesis and release in GH cells: evidence that adenosine 3',5'-monophosphate does not mediate the decrease in growth hormone synthesis caused by thyrotropin-releasing hormone. Endocrinology (1980) 0.77
A possible differentiation of anterior pituitary cells in collagen gels into neurons. Cell Tissue Res (1986) 0.77
Comparison of patterns of prolactin release in GH4C1 cells and primary pituitary cultures. Mol Cell Endocrinol (1985) 0.77
Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion. Eur J Pharmacol (1991) 0.77
Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor. Endocrinology (1979) 0.77
Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding. Psychopharmacology (Berl) (1987) 0.76
Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity. Endocrinology (1984) 0.76
Effects of estradiol on prolactin production and dihydroergocryptine-induced inhibition of prolactin production in primary cultures of rat pituitary cells. Endocrinology (1980) 0.76
Unique properties of norepinephrine release from terminals arising from the locus coeruleus: high potassium sensitivity and lack of linopirdine (DuP 996) enhancement. Neurosci Lett (1993) 0.76
[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol (2000) 0.76
Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures. Mol Cell Endocrinol (1986) 0.76